Notable 52-Week Highs and Lows of the Day 02/21: (M) (HD) (MRO) High; (CHTP) (CDXS) Low

FREE Breaking News Alerts from StreetInsider.com!

M Hot Sheet

Overall Analyst Rating:
BUY ( Down

Down)

Dividend Yield: 2.1%
EPS Growth %: +43.3%

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today.

52-Week High:

Macy's (NYSE: M) high of $38.21. Coming off the new high this afternoon, Macy's was up 5.4 percent at one point. Earlier, Macy's reported fourth-quarter earnings of $1.70 per share on revenue of $8.72 billion. The Street was looking for EPS of $1.65 and revenue of $8.70 billion. Macy's sees fiscal 2012 EPS of $3.25 to $3.30 and comps up 3.5 percent for the year. Currently, the Street expects EPS of $3.27 in 2012.
Home Depot, Inc. (NYSE: HD) high of $48.07. Home Depot is ticking higher Tuesday following quarterly numbers. Earnings were 50 cents per share on revenue of $16.01 billion, both beating expectations calling for EPS of 42 cents and revenue of $15.50 billion.

Including stock buybacks, Home Depot sees fiscal 2012 EPS of $2.79, compared with the consensus of $2.77. Excluding the buybacks and that outlook drops to $2.72.
Marathon Oil (NYSE: MRO) high of $34.79. Marathon Oil is seeing a little uptick Tuesday as crude moves higher on a debt agreement in Greece, which is sending crude prices higher on expected demand increases and a weaker U.S. dollar. Marathon moved 3 percent to its new 52-week high.
SBA Communications (Nasdaq: SBAC) high of $47.28. Earlier in the session, SBA announced its intent to acquire about 2,300 towers and outdoor distributed antenna system (DAS) assets in Chicago, Las Vegas, New York City and Auburn, Alabama for about $1.09 billion in cash and stock. Though at least one analyst said SBA paid too much for the position, investors like the initiative and expansion possibility for SBA, sending the stock 2.2 percent higher Tuesday.

52-Week Low:

Chelsea Therapeutics (Nasdaq: CHTP) low of $2.18. Chelsea hit Tuesday following the posting of FDA documents. Chelsea is expected to meet with an FDA panel to discuss NORTHERA on February 23rd. Notably, the FDA panel is recommending NORTHERA not be approved at this time. Shares moved 35 percent lower to the new mark.
Codexis, Inc. (Nasdaq: CDXS) low of $3.70. Earlier, Codexis announced the appointment of Peter Strumph as the company's interim Chief Executive Officer. Current CEO Alan Shaw resigned his position and from the Board of Directors to pursue other interests.

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!